Jorge Conde

speaker

469 appearances 4 recordings 1 series first heard Sep 2025 last heard 2 Sep

Jorge Conde’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 2 in all, peaking in Sep 2026 with 1.

Appearances

newest first · ▶ plays the moment

The a16z Show · Faster Science, Better Drugs · 15 Sep 2025 podcast

That that that's that's a very sort of laudable, ambitious goal.

If we can figure out how to model the fundamental unit of biology, the cell, then from that we should be able to build.

Yeah.

That's remarkable.

Yeah, so I'll I'll take the the the second one first, if I could.

So I think, you know, in terms of of where the industry is right now, I think one of the big challenges we have is as Patrick describes very nicely, like

You know, discovery's hard and it takes time.

And, you know, the fail modes are exactly as you described.

Oftentimes when drugs fail, which they do ninety percent of the time in clinical trials, it's because we're going after the wrong thing.

Or we made the wrong thing to go after the right thing, right?

Like those are the two fail modes and that happens uh all too often.

And so I think a lot of the stuff that Patrick is describing is gonna basically improve our hit rate or our batting average on figuring out what to go after and then making the right thing to go after set thing.

Um, the challenge we have, I think, in the industry is that the bottlenecks still are the bottlenecks.

And the biggest bottleneck we have, which is, you know, a necessary one, is we have to prove that whatever we make.

That we have the right thing to go after the right thing, so to speak, and that we when we have it, that it's going to be as, you know, de-risked as possible before you put it into humans.

Yeah, exactly.

And so that bottleneck is a necessarily important one.

We that bottlenecks should exist.

I'm not suggesting we better remove it, but are there ways to reduce the cost and time associated?

with getting through the bottleneck of human clinical trials.

Showing 321–340 of 469 · page 17 of 24